Healthcare -
Biotechnology - NASDAQ - US
$ 0.2676
-6.95 %
$ 17.3 M
Market Cap
-0.43
P/E
GLYC - CASH & EQUIVALENTS
Cash & Equivalents GLYC - GlycoMimetics, Inc.
41.8 M
LAST VALUE
-31.95%
2 YEAR CAGR
-27.59%
5 YEAR CAGR
33.58%
10 YEAR CAGR